Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

20 Apr, 2017, 12:15 ET ARMO BioSciences Announces Clinical Data Presentations for Immunotherapy AM0010 at ASCO 2017 Annual Meeting

ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that five abstracts with clinical data on the Company's lead...


20 Apr, 2017, 11:35 ET Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting

Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of...


20 Apr, 2017, 10:29 ET HKSTP Welcomes Maz World to Hong Kong's Vibrant Ecosystem to Commercialise Revolutionary Ostrich Antibody Technology from Japan

Underscoring Hong Kong's status as a biotechnology hub, Maz World Ltd (Maz World) is moving to Hong Kong Science Park to commercialise its...


20 Apr, 2017, 09:38 ET Life science researchers across Michigan to pitch innovation ideas at 2017 Biomedical Innovation Cup

In May, University of Michigan's Fast Forward Medical Innovation (FFMI) will gather some of the most promising innovation projects of the year from...


20 Apr, 2017, 09:00 ET Paradigm Diagnostics Announces Active Clinical Trial Site Enrollment for Personalized Medicine Cancer Registry

Paradigm Diagnostics today announced the launch and IRB approval of the Paradigm registry to allow physicians to better collect, share, and...


20 Apr, 2017, 09:00 ET IriSys Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value

IriSys, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was...


20 Apr, 2017, 09:00 ET Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company...


20 Apr, 2017, 08:50 ET Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced...


20 Apr, 2017, 08:30 ET Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference on...


20 Apr, 2017, 08:00 ET MuscleSound and Colorado Rockies Celebrate Five-Year Partnership

MuscleSound®, a Denver-based performance and health technology company that discovered and developed the only non-invasive way of measuring...


20 Apr, 2017, 08:00 ET Congenica and Edico Genome Partner to Speed Analysis from 'DNA to Diagnosis' for Inherited Diseases

Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome...


20 Apr, 2017, 07:30 ET AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved 99 Percent SVR(12) Rate in Chronic Hepatitis C Patients with Compensated Cirrhosis

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that 99 percent (n=145/146) of chronic hepatitis C virus (HCV) infected...


20 Apr, 2017, 07:30 ET Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses suggested by newborn screening

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced the addition of 80 new panels alongside...


20 Apr, 2017, 07:00 ET Research and Markets - Global Biosimilar Pipeline and Market Prospects 2017-2022: Focus on Basaglar, Inflectra, Benepali, Rituximab, Trastuzumab, Adalimumab and Bevacizumab

Research and Markets has announced the addition of the "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities...


20 Apr, 2017, 07:00 ET Prometic's PBI-4050 Shown to Reduce Liver Damage and Fibrosis in High-Fat Diet Induced Obesity and Metabolic Syndrome Mouse Model

- Strong correlation of results with phase 2 clinical data in metabolic syndrome with type 2 diabetes patients - New data presented at...


20 Apr, 2017, 06:15 ET Biotech Stocks Under Scanner -- Biostage, Keryx Biopharma, Kite Pharma, and ZIOPHARM Oncology

For today, Stock-Callers.com redirects investors' attention to Biotechnology, an industry that focuses on novel drug development and clinical...


20 Apr, 2017, 05:07 ET Brainstorm Cell Therapeutics to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...


20 Apr, 2017, 03:00 ET Eyevensys Receives Approval From the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables...


20 Apr, 2017, 03:00 ET Dutch Philosopher Koert van Mensvoort, Founder of the Next Nature Network, Writes a Letter to Humanity

Dutch philosopher Koert van Mensvoort - founder of the Next Nature Network and Fellow of 'Next Nature' at the University of Technology in...


20 Apr, 2017, 03:00 ET Der niederländische Philosoph Koert van Mensvoort, Gründer von Next Nature Network, schreibt einen Brief an die Menschheit

Der niederländische Philosoph Koert van Mensvoort, Gründer von Next Nature Network und Fellow von "Next Nature" an der Technischen...


20 Apr, 2017, 03:00 ET El filósofo neerlandés Koert van Mensvoort, fundador de la Next Nature Network, escribe una carta a la humanidad

El filósofo neerlandés Koert van Mensvoort, fundador de la Next Nature Network y miembro de "Next Nature" en la Universidad Técnica de Eindhoven,...


20 Apr, 2017, 03:00 ET Le philosophe néerlandais Koert van Mensvoort, fondateur du Next Nature Network, écrit une lettre à l'humanité

Le philosophe néerlandais Koert van Mensvoort, fondateur du Next Nature Network et professeur de « Next Nature » à l'université de technologie...


20 Apr, 2017, 01:30 ET ThromboGenics Achieves Important Milestone in the Development of THR-149, A Novel Plasma Kallikrein Inhibitor for Diabetic Macular Edema

ThromboGenics, a biotechnology company focusing on novel treatments for back of the eye disease and diabetic eye disease, announced it has...


19 Apr, 2017, 17:50 ET AbbVie Announces Topline Results from Two Phase 3 Studies Investigating Veliparib in Combination with Chemotherapy for the Treatment of Patients with Advanced or Metastatic Squamous Non-Small Cell Lung Cancer and Early-Stage Triple-Negative Breast Cancer

AbbVie, a global biopharmaceutical company, today announced that two Phase 3 studies evaluating veliparib, an investigational, oral poly (adenosine...


19 Apr, 2017, 16:30 ET Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published...


Most Viewed